Optimización del despistaje de cáncer de urotelio con Biomarcadores
Domínguez Escrig, José L; Rubio Briones, José.
Arch. esp. urol. (Ed. impr.)
; 75(2): 126-132, mar. 28, 2022.
Artículo en Español | IBECS (España) | ID: ibc-203674
Documentos relacionados
Urinary biomarkers for the optimization of bladder cancer screening.
Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice.
Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
Comprehensive Urinary Proteome Profiling Analysis Identifies Diagnosis and Relapse Surveillance Biomarkers for Bladder Cancer.
Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development.
Mass spectrometry based proteome profiling of the exhaled breath condensate for lung cancer biomarkers search.
Colorimetric Paper-Based Sensors against Cancer Biomarkers.
Potential biomarkers in endometrial cancer: a narrative review.
Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS.
A Biomarker Harvest from One Thousand Cancer Cell Lines.